Collegium Pharmaceutical, Inc. 354.F Stock
Collegium Pharmaceutical, Inc. Price Chart
Collegium Pharmaceutical, Inc. 354.F Financial and Trading Overview
| Collegium Pharmaceutical, Inc. stock price | 34 EUR |
| Previous Close | 20.2 EUR |
| Open | 19.9 EUR |
| Bid | 19.9 EUR x 70000 |
| Ask | 20.4 EUR x 70000 |
| Day's Range | 19.9 - 19.9 EUR |
| 52 Week Range | 14.6 - 27 EUR |
| Volume | 24 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 688.44M EUR |
| Beta (5Y Monthly) | 0.808098 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 1.2 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.71 EUR |
354.F Valuation Measures
| Enterprise Value | 1.26B EUR |
| Trailing P/E | N/A |
| Forward P/E | 4.543379 |
| PEG Ratio (5 yr expected) | 10.2 |
| Price/Sales (ttm) | 1.311435 |
| Price/Book (mrq) | 3.829132 |
| Enterprise Value/Revenue | 2.393 |
| Enterprise Value/EBITDA | 6.053 |
Trading Information
Collegium Pharmaceutical, Inc. Stock Price History
| Beta (5Y Monthly) | 0.808098 |
| 52-Week Change | 42.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27 EUR |
| 52 Week Low | 14.6 EUR |
| 50-Day Moving Average | 20.83 EUR |
| 200-Day Moving Average | 21.01 EUR |
354.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 34.59M |
| Float | 31.14M |
| Short Ratio | N/A |
| % Held by Insiders | 1.01% |
| % Held by Institutions | 109.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -5.59% |
| Operating Margin (ttm) | 9.51% |
| Gross Margin | 74.90% |
| EBITDA Margin | 39.53% |
Management Effectiveness
| Return on Assets (ttm) | 2.53% |
| Return on Equity (ttm) | -15.62% |
Income Statement
| Revenue (ttm) | 524.95M EUR |
| Revenue Per Share (ttm) | 15.44 EUR |
| Quarterly Revenue Growth (yoy) | 72.89% |
| Gross Profit (ttm) | 345.74M EUR |
| EBITDA | 207.54M EUR |
| Net Income Avi to Common (ttm) | -29359000 EUR |
| Diluted EPS (ttm) | -0.82 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 269.48M EUR |
| Total Cash Per Share (mrq) | 7.79 EUR |
| Total Debt (mrq) | 806.24M EUR |
| Total Debt/Equity (mrq) | 448.58 EUR |
| Current Ratio (mrq) | 1.207 |
| Book Value Per Share (mrq) | 5.197 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 177.22M EUR |
| Levered Free Cash Flow (ttm) | 154.35M EUR |
Profile of Collegium Pharmaceutical, Inc.
| Country | Germany |
| State | MA |
| City | Stoughton |
| Address | 100 Technology Center Drive |
| ZIP | 02072 |
| Phone | 781 713 3699 |
| Website | https://www.collegiumpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 207 |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Q&A For Collegium Pharmaceutical, Inc. Stock
What is a current 354.F stock price?
Collegium Pharmaceutical, Inc. 354.F stock price today per share is 34 EUR.
How to purchase Collegium Pharmaceutical, Inc. stock?
You can buy 354.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Collegium Pharmaceutical, Inc.?
The stock symbol or ticker of Collegium Pharmaceutical, Inc. is 354.F.
Which industry does the Collegium Pharmaceutical, Inc. company belong to?
The Collegium Pharmaceutical, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Collegium Pharmaceutical, Inc. have in circulation?
The max supply of Collegium Pharmaceutical, Inc. shares is 32.71M.
What is Collegium Pharmaceutical, Inc. Price to Earnings Ratio (PE Ratio)?
Collegium Pharmaceutical, Inc. PE Ratio is 28.33333200 now.
What was Collegium Pharmaceutical, Inc. earnings per share over the trailing 12 months (TTM)?
Collegium Pharmaceutical, Inc. EPS is 1.2 EUR over the trailing 12 months.
Which sector does the Collegium Pharmaceutical, Inc. company belong to?
The Collegium Pharmaceutical, Inc. sector is Healthcare.